SCHEMBL12445295

SCHEMBL12445295

Cc1ccc(COCC(F)(F)C(F)(F)COS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.44
CA1 P00915 2/20 0.44
CA9 Q16790 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.40
LMNA P02545 5/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.40
BCHE P06276 3/20 0.39
ACHE P22303 3/20 0.39
GAA P10253 3/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
ALDH1A1 P00352 4/20 0.38
PTPRZ1 P23471 1/20 0.37
STAT3 P40763 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
PTPN1 P18031 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19436459 0.88 GAA (0.43) CA2CA1CA9SMN1; SMN2MEN1
SCHEMBL2533175 0.82 GAA (0.41) CA2CA1CA9SMN1; SMN2MEN1
SCHEMBL23882162 0.81 STAT3 (0.41) CA2CA1CA9SMN1; SMN2MEN1
SCHEMBL28268959 0.80 ALDH1A1 (0.41) CA2CA1CA9MEN1KMT2A
SCHEMBL30840744 0.79 ALDH1A1 (0.40) CA2CA1CA9SMN1; SMN2LMNA
SCHEMBL68796 0.78 GAA (0.43) CA2CA1CA9MEN1KMT2A
SCHEMBL1980138 0.78 GAA (0.43) CA2CA1CA9SMN1; SMN2MEN1
SCHEMBL6859827 0.78 CA2 (0.63) CA2CA1CA9MEN1KMT2A
SCHEMBL8052920 0.78 CA2 (0.63) CA2CA1CA9MEN1KMT2A
SCHEMBL30831536 0.78 ALDH1A1 (0.47) CA2CA1CA9SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481774-B2 Method for producing tetrafluoro compound NIPPON SODA CO., LTD. (JP) 2013-07-09 US disclosed
US-20110178323-A1 METHOD FOR PRODUCING TETRAFLUORO COMPOUND NIPPON SODA CO., LTD. (JP) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178323-A1 METHOD FOR PRODUCING TETRAFLUORO COMPOUND F9, CA9, TAF9 CA2 301/4885CA1 284/4885CA9 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.